Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May 25;10(11):2287.
doi: 10.3390/jcm10112287.

Characteristics of Moyamoya Disease in the Older Population: Is It Possible to Define a Typical Presentation and Optimal Therapeutical Management?

Affiliations
Review

Characteristics of Moyamoya Disease in the Older Population: Is It Possible to Define a Typical Presentation and Optimal Therapeutical Management?

Ignazio G Vetrano et al. J Clin Med. .

Abstract

Whereas several studies have been so far presented about the surgical outcomes in terms of mortality and perioperative complications for elderly patients submitted to neurosurgical treatments, the management of elderly moyamoya patients is unclear. This review aims to explore the available data about the clinical manifestation, characteristics, and outcome after surgery of older patients with moyamoya arteriopathy (MA). We found only two articles strictly concerning elderly patients with MA. We have also evaluated other reported adult series of moyamoya patients, including elderly cases in their analysis. Patients with MA above 50 years old may be considered a peculiar subset in which patients are often presenting with ischemic symptoms and a higher Suzuki grade. Conservative treatment may be proposed in asymptomatic or stable cases due to their fragility and possible increase of post-operative complications, while the best surgical options in symptomatic cases are still under investigation, although we believe that a minimal invasive superficial temporal artery-middle cerebral artery bypass could be considered the treatment of choice for the immediate effect on brain perfusion with a limited rate of post-operative complications.

Keywords: cerebral angiopathy; elderly; extracranial-intracranial bypass; internal carotid artery; middle cerebral artery; moyamoya; revascularization; superficial temporal artery.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Kuroda S., Houkin K. Moyamoya disease: Current concepts and future perspectives. Lancet. Neurol. 2008;7:1056–1066. doi: 10.1016/S1474-4422(08)70240-0. - DOI - PubMed
    1. Suzuki J., Takaku A. Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch. Neurol. 1969;20:288–299. doi: 10.1001/archneur.1969.00480090076012. - DOI - PubMed
    1. Tinelli F., Nava S., Arioli F., Bedini G., Scelzo E., Lisini D., Faragò G., Gioppo A., Ciceri E.F., Acerbi F., et al. Vascular Remodeling in Moyamoya Angiopathy: From Peripheral Blood Mononuclear Cells to Endothelial Cells. Int. J. Mol. Sci. 2020;21:5763. doi: 10.3390/ijms21165763. - DOI - PMC - PubMed
    1. Bersano A., Guey S., Bedini G., Nava S., Hervé D., Vajkoczy P., Tatlisumak T., Sareela M., Van Der Zwan A., Klijn C.J.M., et al. Research progresses in understanding the pathophysiology of moyamoya disease. Cerebrovasc. Dis. 2016;41:105–118. doi: 10.1159/000442298. - DOI - PubMed
    1. Bedini G., Blecharz K.G., Nava S., Vajkoczy P., Alessandri G., Ranieri M., Acerbi F., Ferroli P., Riva D., Esposito S., et al. Vasculogenic and Angiogenic Pathways in Moyamoya Disease. Curr. Med. Chem. 2016;23:315–345. doi: 10.2174/092986732304160204181543. - DOI - PubMed